Files in This Item:


Title: Should early antiretroviral therapy (CD4 > 350 cells/mm3) vs deferred antiretroviral therapy (CD4 < 350 cells/mm3) be used for prevention of tuberculosis?
Authors: World Health Organization
Suthar, A B
Lawn, S D
del Amo, J
Getahun, H
Dye, C
Sculier, D
Sterling, T R
Chaisson, R E
Williams, B G
Harries, A D
Granich, R M
Issue Date: 2013
Publisher: World Health Organization
Place of publication: Geneva
Language: English
Description: 1 p.
Subject: HIV Infections
Anti-Retroviral Agents
Context: drug therapy
prevention and control
Gov't Doc #: WHO/HIV/2013.21
Appears in Collections:Technical Documents

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.